| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 07/21/2005 | US20050158409 Beverage with proanthocyanidins; protecting blood vessels |
| 07/21/2005 | US20050158360 From a two-layered polymeric matrix including incompatible polymers, the top layer controls elution rate of said drugs; e.g. fluoropolymer layer covered with a polyacrylate top layer; stents, anastomotic devices |
| 07/21/2005 | US20050158317 Novel proteins with il-6 inhibiting activity |
| 07/21/2005 | US20050158288 Methods of organ regeneration |
| 07/20/2005 | EP1555032A1 Medicinal composition for treating arteriosclerosis |
| 07/20/2005 | EP1555031A1 Angiogenesis inducer |
| 07/20/2005 | EP1555030A1 Sustained release preparation for treating coronary stenosis or obstruction |
| 07/20/2005 | EP1554572A2 Compositions and methods for modulating blood-brain barrier transport |
| 07/20/2005 | EP1554393A2 P27 prevents cellular migration |
| 07/20/2005 | EP1554280A2 Antidiabetic beta-amino heterocyclic dipeptidyl peptidase inhibitors |
| 07/20/2005 | EP1554275A2 Compounds |
| 07/20/2005 | EP1554268A1 Pyrazole inhibitors of the transforming growth factor |
| 07/20/2005 | EP1554267A1 Dihydropyridine compounds having simultaneous ability to block l-type calcium channels and to inhibit phosphodiesterase type 3 activity |
| 07/20/2005 | EP1554265A2 Compounds, compositions and methods |
| 07/20/2005 | EP1554263A1 N-benzodioxolyl, n-benzodioxanyl and n-benzodioxepinyl arylcarbonxamide derivatives, and pharmaceutical compositions comprising them |
| 07/20/2005 | EP1554256A1 Piperidino pyrimidine dipeptidyl peptidase inhibitors for the treatment of diabetes |
| 07/20/2005 | EP1554253A1 Imidazolium cxcr3 inhibitors |
| 07/20/2005 | EP1554245A1 Piperidinetriol derivatives as inhibitors of glycosylceramidsynthase |
| 07/20/2005 | EP1553973A2 eNOS MUTANTS USEFUL FOR GENE THERAPY |
| 07/20/2005 | EP1553965A2 Method of treating tumors |
| 07/20/2005 | EP1553960A1 Neuregulin based methods and compositions for treating cardiovascular diseases |
| 07/20/2005 | EP1553957A1 Bisphosphonates for the treatment of atherosclerosis and devices comprising them |
| 07/20/2005 | EP1553954A2 Dihydrate dehydroepiandrosterone and methods of treating asthma or chronic obstructive pulmonary disease using compostions thereof |
| 07/20/2005 | EP1553941A1 Lisinopril/lercanidipine combination therapy |
| 07/20/2005 | EP1553932A2 Derivatives of n-phenylanthranilic acid and 2-benzimidazolon as potassium channel and/or cortical neuron activity modulators |
| 07/20/2005 | EP1553931A1 Compounds, compositions, and methods |
| 07/20/2005 | EP1553924A1 Novel method of stabilizing diagnostic and therapeutic compounds in a cationic carrier system |
| 07/20/2005 | EP1553923A1 Camptothecin-carboxylate formulations |
| 07/20/2005 | EP1472251B1 Novel fluorene carboxylic acid esters, methods for the production thereof, and use of the same as pharmaceuticals |
| 07/20/2005 | EP1392670B1 Substituted c-furan-2-yl-methylamine and c-thiophen-2-yl-methylamine derivatives |
| 07/20/2005 | EP1381606B1 Imidazo-pyrimidine derivatives as ligands for gaba receptors |
| 07/20/2005 | EP1345605B1 THERMOFORMed SOLID PHARMACEUTICAL COMPOSITION FOR CONTROLLED RELEASE OF PERINDOPRIL |
| 07/20/2005 | EP1303512B1 Process for preparing arylacetylaminothiazoles |
| 07/20/2005 | EP1286673B8 Ligands of integrin receptors |
| 07/20/2005 | EP1284959B1 Compounds for modulating the rage receptor |
| 07/20/2005 | EP1272484B1 Benzoamide piperidine compounds as substance p antagonists |
| 07/20/2005 | EP1261328B1 Il-8 receptor antagonists |
| 07/20/2005 | EP1244672B1 4-substituted 7-aza-indolin-2-ones and their use as protein kinase inhibitors |
| 07/20/2005 | EP1241254B1 Apoptosis inhibitory polypeptide, gene and polynucleotide encoding it and compositions containing the same |
| 07/20/2005 | EP1229965B1 Placental human neurokinin b precursor |
| 07/20/2005 | EP1189583B1 Indole derivatives |
| 07/20/2005 | EP1129077B9 Fluorinated 3,4-dihydroquinoline derivatives used as nos inhibitors |
| 07/20/2005 | EP0703785B1 Methods for treating muscle diseases and disorders |
| 07/20/2005 | CN1643149A Hybrid hepatocyte growth factor gene having high expression efficiency of two heterotypes of hepatocyte growth factor |
| 07/20/2005 | CN1643137A Dedifferentiated, programmable stem cells of monocytic origin, and their production and use |
| 07/20/2005 | CN1643135A Isolated homozygous stem cells differentiated cells derived therefrom and materials and methods for making and using same |
| 07/20/2005 | CN1643134A Method for producing pseudo islets |
| 07/20/2005 | CN1642983A Antibodies against of C5aR and use thereof |
| 07/20/2005 | CN1642980A Antagonistic anti-hFAS ligand human antibodies and fragments thereof |
| 07/20/2005 | CN1642979A VEGF peptides and their use |
| 07/20/2005 | CN1642971A A nucleic acid encoding a G-protein-coupled receptor, and uses thereof |
| 07/20/2005 | CN1642970A Process for producing triterpene derivative |
| 07/20/2005 | CN1642961A Aminomethyl-substituted thiazolobenzimidazole derivative |
| 07/20/2005 | CN1642955A Novel alkoxypyridine-derivatives |
| 07/20/2005 | CN1642948A Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase |
| 07/20/2005 | CN1642944A (3Z) -3-(2, 3-dihydro-1H-ylidene)-1, 3-dihydro-2H-indol-2-ones as kinase inhibitors |
| 07/20/2005 | CN1642938A New compounds |
| 07/20/2005 | CN1642933A Cyclic hemiacetal derivative and use thereof |
| 07/20/2005 | CN1642927A Cyclic amides |
| 07/20/2005 | CN1642918A Novel hererocyclic compound and preparation thereof and medicine composition containing same and use thereof in medicine |
| 07/20/2005 | CN1642912A Sulfonylamino-derivatives as novel inhibitors of histone deacetylase |
| 07/20/2005 | CN1642907A Carbonylamino-derivatives as novel inhibitors of histone deacetylase |
| 07/20/2005 | CN1642904A Salts of nateglinide |
| 07/20/2005 | CN1642580A Radiolabelled quinoline and quinolinone derivatives and their use as metabotropic glutamate receptor ligands |
| 07/20/2005 | CN1642573A Combination of an aldosterone receptor antagonist and a fibric acid derivative |
| 07/20/2005 | CN1642567A HIV inhibiting proteins |
| 07/20/2005 | CN1642559A Combination comprising an HMG-CoA reductase inhibitor and an insulin secretor enhancer or an insulin sensitizer |
| 07/20/2005 | CN1642558A Theraputic methods and uses of sapogenins and their derivatives |
| 07/20/2005 | CN1642557A Combination of an aldosterone receptor antagonist and nicotinic acid or a nicotinic acid derivative |
| 07/20/2005 | CN1642556A Combination of an aldosterone receptor antagonist and a bile acid sequestering agent |
| 07/20/2005 | CN1642551A Inhibitors of histone deacetylase |
| 07/20/2005 | CN1642550A Beta-sheet mimetics and composition and methods relating thereto |
| 07/20/2005 | CN1642542A Angiogenesis inhibitors |
| 07/20/2005 | CN1642538A Use of adapalene for the treatment of dermatological disorders |
| 07/20/2005 | CN1642536A Agents for corneal or intrastromal administration to treat or prevent disorders of the eye |
| 07/20/2005 | CN1642528A Stable salts of O-acetylsalicylic acid containing basic amino acids II |
| 07/20/2005 | CN1640877A Novel spiro compounds |
| 07/20/2005 | CN1640488A Method for preparing supermicro powder preparation of cordyceps sinensis mycelium |
| 07/20/2005 | CN1640484A Chinese medicine soft capsule Naodesheng and its preparing method |
| 07/20/2005 | CN1640478A External-use Chinese medicine preparation for treating anal-intestinal disorder and its preparing method |
| 07/20/2005 | CN1640447A Method for preparing medicine for treating viral carditis and its use |
| 07/20/2005 | CN1640445A Fresh eucommia leaf preparation and its preparing method |
| 07/20/2005 | CN1640444A Fresh tea juice preparation and its preparing method |
| 07/20/2005 | CN1640443A Rhizome gastrodiae preparation and its preparing method |
| 07/20/2005 | CN1640442A Fresh multiflower knotweed tuber preparation and its preparing method |
| 07/20/2005 | CN1640435A Beta-cyclodextrin and polyoxyethylenated castor oil for preparing injection liquid for restoring conscious ness and its preparing method |
| 07/20/2005 | CN1640421A Injection danhong of radix salviae miltorrhizae and flos carthami, and its preparing method and quality control method |
| 07/20/2005 | CN1640417A Chinese medicine drop pill formula for treating coronary disease and its preparing method |
| 07/20/2005 | CN1640409A High-purity scutellarin injection agent |
| 07/20/2005 | CN1640400A Felodipine controlled-release preparation |
| 07/20/2005 | CN1640395A Supermolecular intercalation-structure slow-release captopril and its preparing method |
| 07/20/2005 | CN1640392A High-dose hydroxy safflower yellow A or its medically-acceptable salt application for preparing medicine for cerebral apoplexy induced from being ischemic |
| 07/20/2005 | CN1640391A Tanshinon IIA sulfonic acid sodium glucose injection liquid and its preparing method |
| 07/20/2005 | CN1640283A Method for preparing tea for bringing high blood pressure down |
| 07/20/2005 | CN1211383C Process for making substituted 8-arylquinolinium benzenesulfonate |
| 07/20/2005 | CN1211375C Thiazole-derivatives |
| 07/20/2005 | CN1211374C Heterocyclic derivative, its preparation method and medicine compositioncontaining them |
| 07/20/2005 | CN1211373C 2,d-di (hetero-) arylamino (-oxy)-5-substituted pyrimidines as antineoplastic agents |
| 07/20/2005 | CN1211370C Biphenylsulfonyl-substd. imidazole derivs., their preparation process, their use as drug or diagnostic agent |
| 07/20/2005 | CN1211368C Amorphous torasemide modification |